VLDLR

Chr 9AR

very low density lipoprotein receptor

Also known as: CAMRQ1, CARMQ1, CHRMQ1, VLDL-R, VLDLRCH

The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. This gene encodes a lipoprotein receptor that is a member of the LDLR family and plays important roles in VLDL-triglyceride metabolism and the reelin signaling pathway. Mutations in this gene cause VLDLR-associated cerebellar hypoplasia. Alternative splicing generates multiple transcript variants encoding distinct isoforms for this gene. [provided by RefSeq, Aug 2009]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.721 OMIM phenotype
Clinical SummaryVLDLR
🧬
Gene-Disease Validity (ClinGen)
cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1 · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
66 unique Pathogenic / Likely Pathogenic· 221 VUS of 865 total submissions
📖
GeneReview available — VLDLR
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.72LOEUF
pLI 0.000
Z-score 3.17
OE 0.52 (0.380.72)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
-1.12Z-score
OE missense 1.15 (1.071.23)
534 obs / 465.9 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.52 (0.380.72)
00.351.4
Missense OE?1.15 (1.071.23)
00.61.4
Synonymous OE?1.17
01.21.6
LoF obs/exp: 26 / 50.3Missense obs/exp: 534 / 465.9Syn Z: -1.74
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveVLDLR-related cerebellar ataxia, intellectual developmental disorder, and dysequilibrium syndromeLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6646th %ile
GOF
0.74top 25%
LOF
0.3260th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

865 submitted variants in ClinVar

Classification Summary

Pathogenic36
Likely Pathogenic30
VUS221
Likely Benign483
Benign47
Conflicting34
36
Pathogenic
30
Likely Pathogenic
221
VUS
483
Likely Benign
47
Benign
34
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
30
2
4
0
36
Likely Pathogenic
27
3
0
0
30
VUS
1
182
32
6
221
Likely Benign
0
6
248
229
483
Benign
0
0
46
1
47
Conflicting
34
Total58193330236851

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

177 pathogenic / likely-pathogenic (of 206) ClinVar copy-number / structural variants overlap VLDLR — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

VLDLR · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →